Evidence map›Paper›PMID 36234487›Full record

ReviewNanomaterials (Basel, Switzerland)2022

MXenes in Cancer Nanotheranostics.

Siavash Iravani, Rajender S Varma

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. The Emerging Role of MXenes in Cancer Treatment.International journal of molecular sciences · 2025
    Review
  10. Review
  11. MXene and prostate cancer: is there promising news?Nanomedicine (London, England) · 2025
    Review
  12. Review
  13. Review
  14. Review
  15. MXene: A wonderful nanomaterial in antibacterial.Frontiers in bioengineering and biotechnology · 2024
    Review
  16. Review
  17. MXene-Carbon Nanotube Composites: Properties and Applications.Nanomaterials (Basel, Switzerland) · 2023
    Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Siavash IravaniFaculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.ORCID 0000-0003-3985-7928
Rajender S VarmaRegional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacký University in Olomouc, Šlechtitelů 27, 783 71 Olomouc, Czech Republic.ORCID 0000-0001-9731-6228
Isfahan University of Medical Sciences · IRRegional Centre of Advanced Technologies and Materials · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MXenes encompass attractive properties such as a large surface area, unique chemical structures, stability, elastic mechanical strength, excellent electrical conductivity, hydrophilicity, and ease of surface functionalization/modifications, which make them one of the broadly explored two-dimensional materials in the world. MXene-based micro- and nanocomposites/systems with special optical, mechanical, electronic, and excellent targeting/selectivity features have been explored for cancer nanotheranostics. These materials exhibit great diagnostic and therapeutic potential and offer opportunities for cancer photoacoustic imaging along with photodynamic and photothermal therapy. They can be applied to targeted anticancer drug delivery while being deployed for the imaging/diagnosis of tumors/cancers and malignancies. MXene-based systems functionalized with suitable biocompatible or bioactive agents have suitable cellular uptake features with transferring potential from vascular endothelial cells and specific localization, high stability, and auto-fluorescence benefits at different emission-excitation wavelengths, permitting post-transport examination and tracking. The surface engineering of MXenes can improve their biocompatibility, targeting, bioavailability, and biodegradability along with their optical, mechanical, and electrochemical features to develop multifunctional systems with cancer theranostic applications. However, challenges still persist in terms of their environmentally benign fabrication, up-scalability, functionality improvement, optimization conditions, surface functionalization, biocompatibility, biodegradability, clinical translational studies, and pharmacokinetics. This manuscript delineates the recent advancements, opportunities, and important challenges pertaining to the cancer nanotheranostic potential of MXenes and their derivatives.

Indexed as

cancer diagnosticscancer therapeuticsMXene-based compositesMXenesnanotheranostics

Identifiers

PMID36234487
PMCPMC9565327
OpenAlexW4297547691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.